A phase I study by Leijen et al. (2016) evaluated the WEE1 inhibitor AZD1775 as monotherapy and in combination with gemcitabine, cisplatin, or carboplatin in patients with advanced solid tumors.

Authors

• Person: Not available Organization: Nature
  Perspectives on cancer therapy—synthetic lethal precision medicine ...

Sources

• Perspectives on cancer therapy—synthetic lethal precision medicine ... www.nature.com Nature via serper

Referenced by nodes (2)

• Adavosertib concept
• cisplatin concept